Klein Lawrence Otto's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed Sep 1, 2026
- Accession no.
- 0000907654-26-000087
- Filed
- Sep 1, 2026, 6:35 PM ET
- Trade date
- Sep 1, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.89M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klein Lawrence OttoCIK 0001762583 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | MOption exerciseAcquired | +75,000 | $7.80 | +$585,000 | 1,000,580 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −6,604 | $90.79 | −$599,556.03 | 993,976 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −63,596 | $91.90 | −$5,844,237.09 | 930,380 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −4,800 | $92.44 | −$443,691.36 | 925,580 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | MOption exerciseDisposed | −75,000 | $0.00 | $0 | 1,553,513 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.